AR112401A1 - ANTI-CD33 ANTIBODIES AND METHODS TO USE THEM - Google Patents
ANTI-CD33 ANTIBODIES AND METHODS TO USE THEMInfo
- Publication number
- AR112401A1 AR112401A1 ARP180102214A AR112401A1 AR 112401 A1 AR112401 A1 AR 112401A1 AR P180102214 A ARP180102214 A AR P180102214A AR 112401 A1 AR112401 A1 AR 112401A1
- Authority
- AR
- Argentina
- Prior art keywords
- antibodies
- compositions
- methods
- epitopes
- chimeric
- Prior art date
Links
Abstract
La presente descripción hace referencia, en líneas generales, a composiciones que incluyen anticuerpos, por ejemplo, anticuerpos monoclonales, quiméricos, humanizados, fragmentos de anticuerpos, etc., que se unen específicamente a uno o más epítopos de una proteína CD33, por ejemplo, CD33 humana o CD33 de mamífero y tienen características funcionales mejoradas y/o potenciadas, y al uso de dichas composiciones para prevenir, reducir el riesgo y tratar a un individuo que lo necesite.The present disclosure refers, broadly, to compositions that include antibodies, for example, monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind to one or more epitopes of a CD33 protein, for example, Human CD33 or mammalian CD33 and have improved and / or enhanced functional characteristics, and the use of said compositions to prevent, reduce the risk and treat an individual in need.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762541024P | 2017-08-03 | 2017-08-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR112401A1 true AR112401A1 (en) | 2019-10-23 |
Family
ID=68382541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180102214 AR112401A1 (en) | 2017-08-03 | 2018-08-03 | ANTI-CD33 ANTIBODIES AND METHODS TO USE THEM |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR112401A1 (en) |
-
2018
- 2018-08-03 AR ARP180102214 patent/AR112401A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP19078414A (en) | ANTI-CD33 ANTIBODIES AND METHODS TO USE THEM | |
| ECSP19078429A (en) | ANTI-TREM2 ANTIBODIES AND METHODS TO USE THEM | |
| EA201792221A1 (en) | ANTIBODIES AGAINST SORTILINE AND METHODS OF THEIR APPLICATION | |
| WO2016201388A3 (en) | Anti-cd33 antibodies and methods of use thereof | |
| WO2016201389A3 (en) | Anti-cd33 antibodies and methods of use thereof | |
| ECSP21010450A (en) | ANTI-SORTILINA ANTIBODIES AND METHODS FOR THEIR USE | |
| WO2017075432A3 (en) | Anti-siglec-9 antibodies and methods of use thereof | |
| WO2017062672A3 (en) | Anti-trem2 antibodies and methods of use thereof | |
| ECSP20082648A (en) | ANTI-SIRPA ANTIBODIES AND METHODS OF USING THEM | |
| WO2017152102A3 (en) | Anti-trem1 antibodies and methods of use thereof | |
| AR100680A1 (en) | ANTI-DR5 ANTIBODIES AND MOLECULES THAT INCLUDE DR5 JOINT DOMAINS OF THE SAME | |
| ECSP21022299A (en) | ANTI-CD33 ANTIBODIES AND METHODS OF USING THEM | |
| PE20181054A1 (en) | HUMANIZED ANTI-CD19 ANTIBODIES AND METHODS OF USE | |
| UY36942A (en) | ANTIGEN UNION PROTEINS THAT ACTIVATE THE LEPTINE RECEIVER | |
| EA202190183A1 (en) | ANTIBODIES TO SIGLEC-5 AND METHODS OF THEIR APPLICATION | |
| EA202092595A1 (en) | ANTIBODIES TO SIGLEC-7 AND METHODS OF THEIR APPLICATION | |
| AR112401A1 (en) | ANTI-CD33 ANTIBODIES AND METHODS TO USE THEM | |
| AR122237A1 (en) | ANTI-SORTILINA ANTIBODIES AND METHODS FOR THEIR USE | |
| EA201992319A1 (en) | ANTI-CD33 ANTIBODIES AND WAYS OF THEIR APPLICATION | |
| AR100523A1 (en) | MAPPING OF EPITOPES OF THE HUMANIZED MONOCLONAL ANTIBODIES AGAINST ACTIVATED PROTEIN C AND ITS BACKGROUND USES | |
| AR106198A1 (en) | BISPECIFIC ANTIBODIES FOR THE PROGRAMMED CELL DEATH PROTEIN 1 (PD1) AND FOR THE HUMAN PROTEIN BELONGING TO THE IMMUNOGLOBULIN SUPERFAMILY (TIM3) | |
| EA202090586A2 (en) | TRANSPECIFIC BINDING MOLECULES AND METHODS FOR THEIR APPLICATION |